CAS: 92623-85-3 - Milnacipran
Formula:C15H22N2O
InChI:InChI=1/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/s2
InChI key:InChIKey=GJJFMKBJSRMPLA-UYWMCZCJNA-N
SMILES:O=C(N(CC)CC)C1(C=2C=CC=CC2)CC1CN
- Synonyms:
- Milnacipran
- rel-(1R,2S)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
- Midalcipran
- Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(±)-
- Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1R,2S)-rel-
Milnacipran Hydrochloride
Formula:
C15H22N2O·HCl
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Light yellow powder to crystal
Molecular weight:
282.81
Ref: 3B-M2133
50mg | 34.00 € | ||
500mg | 161.00 € |
Estimated delivery in United States, on Monday 30 Dec 2024
Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-,(1R,2S)-rel-
CAS:92623-85-3
Formula:
C15H22N2O
Color and Shape:
Solid
Molecular weight:
246.3480
Ref: IN-DA00GRBC
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-M-413
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Milnacipran
CAS:92623-85-3
Milnacipran, an SNRI with 85% bioavailability, treats fibromyalgia and is well absorbed orally.
Formula:
C15H22N2O
Color and Shape:
Solid
Molecular weight:
246.35
Ref: TM-T7073
25mg | 1,437.00 € | ||
50mg | 1,872.00 € | ||
100mg | 2,364.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Ref: 4Z-M-412
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
(1R,2S)-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
Controlled ProductCAS:92623-85-3
Riluzole is a drug that inhibits the synthesis of glutamate and aspartate, which are neurotransmitters …
Formula:
C15H22N2O
Purity:
Min. 95%
Molecular weight:
246.35 g/mol
Ref: 3D-SDA62385
250mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025